JP5725861B2 - 可溶性rnaキャップ結合ポケット断片、及びその使用 - Google Patents

可溶性rnaキャップ結合ポケット断片、及びその使用 Download PDF

Info

Publication number
JP5725861B2
JP5725861B2 JP2010528317A JP2010528317A JP5725861B2 JP 5725861 B2 JP5725861 B2 JP 5725861B2 JP 2010528317 A JP2010528317 A JP 2010528317A JP 2010528317 A JP2010528317 A JP 2010528317A JP 5725861 B2 JP5725861 B2 JP 5725861B2
Authority
JP
Japan
Prior art keywords
amino acid
seq
polypeptide fragment
rna
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010528317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011501942A5 (cg-RX-API-DMAC7.html
JP2011501942A (ja
Inventor
キューザック,ステファン
グイリガイ,ディルフィーヌ
ハート,ダレン
タレンデュー,フランク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
European Molecular Biology Laboratory
Original Assignee
European Molecular Biology Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Molecular Biology Laboratory filed Critical European Molecular Biology Laboratory
Publication of JP2011501942A publication Critical patent/JP2011501942A/ja
Publication of JP2011501942A5 publication Critical patent/JP2011501942A5/ja
Application granted granted Critical
Publication of JP5725861B2 publication Critical patent/JP5725861B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0223—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2501/00—Containers having bodies formed in one piece
    • B65D2501/0009—Bottles or similar containers with necks or like restricted apertures designed for pouring contents
    • B65D2501/0018—Ribs
    • B65D2501/0036—Hollow circonferential ribs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers Having Bodies Formed In One Piece (AREA)
JP2010528317A 2007-10-09 2008-10-09 可溶性rnaキャップ結合ポケット断片、及びその使用 Expired - Fee Related JP5725861B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US99839807P 2007-10-09 2007-10-09
US60/998,398 2007-10-09
US7079208P 2008-03-25 2008-03-25
US61/070,792 2008-03-25
US12345608P 2008-04-08 2008-04-08
US61/123,456 2008-04-08
PCT/EP2008/008543 WO2009046983A1 (en) 2007-10-09 2008-10-09 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014207447A Division JP5937169B2 (ja) 2007-10-09 2014-10-08 可溶性rnaキャップ結合ポケット断片、及びその使用

Publications (3)

Publication Number Publication Date
JP2011501942A JP2011501942A (ja) 2011-01-20
JP2011501942A5 JP2011501942A5 (cg-RX-API-DMAC7.html) 2012-09-27
JP5725861B2 true JP5725861B2 (ja) 2015-05-27

Family

ID=40364724

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010528317A Expired - Fee Related JP5725861B2 (ja) 2007-10-09 2008-10-09 可溶性rnaキャップ結合ポケット断片、及びその使用
JP2014207447A Expired - Fee Related JP5937169B2 (ja) 2007-10-09 2014-10-08 可溶性rnaキャップ結合ポケット断片、及びその使用
JP2016094331A Expired - Fee Related JP6309563B2 (ja) 2007-10-09 2016-05-10 可溶性rnaキャップ結合ポケット断片、及びその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014207447A Expired - Fee Related JP5937169B2 (ja) 2007-10-09 2014-10-08 可溶性rnaキャップ結合ポケット断片、及びその使用
JP2016094331A Expired - Fee Related JP6309563B2 (ja) 2007-10-09 2016-05-10 可溶性rnaキャップ結合ポケット断片、及びその使用

Country Status (11)

Country Link
US (1) US9045248B2 (cg-RX-API-DMAC7.html)
EP (2) EP2574619A3 (cg-RX-API-DMAC7.html)
JP (3) JP5725861B2 (cg-RX-API-DMAC7.html)
KR (1) KR101672554B1 (cg-RX-API-DMAC7.html)
CN (1) CN101970465B (cg-RX-API-DMAC7.html)
AU (1) AU2008309939B2 (cg-RX-API-DMAC7.html)
CA (1) CA2701362A1 (cg-RX-API-DMAC7.html)
ES (1) ES2454773T3 (cg-RX-API-DMAC7.html)
IL (3) IL204891A (cg-RX-API-DMAC7.html)
SG (1) SG185289A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009046983A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015062417A (ja) * 2007-10-09 2015-04-09 ヨーロピアン モレキュラー バイオロジー ラボラトリー 可溶性rnaキャップ結合ポケット断片、及びその使用

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
EP2547696B1 (en) * 2010-03-16 2018-05-23 European Molecular Biology Laboratory (Embl) Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
CA2879443A1 (en) * 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
PT3068776T (pt) 2013-11-13 2019-08-26 Vertex Pharma Inibidores da replicação de vírus da gripe
CN105002149B (zh) * 2014-04-22 2018-04-06 中国科学院生物物理研究所 流感病毒rna聚合酶纯化或结晶的方法
CN105018441A (zh) * 2014-04-22 2015-11-04 中国科学院生物物理研究所 流感病毒rna聚合酶结晶的方法
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
CN107286044B (zh) 2016-04-13 2021-07-13 香港神农有限公司 一种能够抑制流感病毒pb2蛋白与rna帽结合的化合物
CL2018003871A1 (es) 2018-12-28 2021-01-15 Univ Pontificia Catolica Chile Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu
WO2020239822A1 (en) 2019-05-27 2020-12-03 The European Molecular Biology Laboratory Nucleic acid construct binding to influenza polymerase pb1 rna synthesis active site
CN113122596B (zh) * 2020-08-20 2023-01-24 深圳市瑞吉生物科技有限公司 一种Cap2结构5′帽子类似物及其制备方法和应用
CN114741315B (zh) * 2022-04-28 2023-06-13 深圳市紫光同创电子有限公司 用例更新方法、装置、电子设备及存储介质
CN116024301B (zh) * 2023-01-16 2025-10-28 北京协同创新研究院 一种rna依赖性rna聚合酶截短体的筛选方法、截短体及应用
WO2025055169A1 (en) * 2023-09-12 2025-03-20 The Chinese University Of Hong Kong A fluorescent probe to measure rna binding and elongation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837852A (en) * 1993-10-14 1998-11-17 Bristol-Myers Squibb Company Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease
KR101672554B1 (ko) * 2007-10-09 2016-11-03 유럽피안 몰레큘러 바이올로지 래보러토리 Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편
JP6614523B2 (ja) * 2014-03-28 2019-12-04 地方独立行政法人神奈川県立産業技術総合研究所 インフルエンザウイルスのrna依存性rnaポリメラーゼのpb2サブユニットに対するモノクローナル抗体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015062417A (ja) * 2007-10-09 2015-04-09 ヨーロピアン モレキュラー バイオロジー ラボラトリー 可溶性rnaキャップ結合ポケット断片、及びその使用

Also Published As

Publication number Publication date
EP2197901A1 (en) 2010-06-23
CA2701362A1 (en) 2009-04-16
CN101970465A (zh) 2011-02-09
EP2197901B1 (en) 2013-12-11
JP2015062417A (ja) 2015-04-09
IL222997A0 (en) 2012-12-31
EP2574619A2 (en) 2013-04-03
IL204891A0 (en) 2010-11-30
AU2008309939B2 (en) 2013-11-14
JP6309563B2 (ja) 2018-04-11
KR101672554B1 (ko) 2016-11-03
SG185289A1 (en) 2012-11-29
JP2016176955A (ja) 2016-10-06
ES2454773T3 (es) 2014-04-11
JP2011501942A (ja) 2011-01-20
US9045248B2 (en) 2015-06-02
IL237903A (en) 2017-10-31
JP5937169B2 (ja) 2016-06-22
KR20100074212A (ko) 2010-07-01
US20110008348A1 (en) 2011-01-13
CN101970465B (zh) 2016-03-16
AU2008309939A1 (en) 2009-04-16
WO2009046983A1 (en) 2009-04-16
EP2574619A3 (en) 2013-07-31
IL204891A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
JP6309563B2 (ja) 可溶性rnaキャップ結合ポケット断片、及びその使用
US20180010109A1 (en) Polypeptide fragments comprising endonuclease activity and their use
US20180044649A1 (en) Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use
HK1179985A (en) Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
HK1183501A (en) Polypeptide fragments comprising endonuclease activity and their use
HK1163166B (en) Polypeptide fragments comprising endonuclease activity and their use
HK1163166A (en) Polypeptide fragments comprising endonuclease activity and their use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110803

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110803

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120801

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130808

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131025

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131101

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131224

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141016

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20141022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150205

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150302

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150331

R150 Certificate of patent or registration of utility model

Ref document number: 5725861

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees